Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 2430 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Medtronic to acquire Ventor Technologies

Medtronic said that this acquisition adds two technologies to its transcatheter valve portfolio: a minimally invasive, surgical transapical technology and a next generation percutaneous, transfemoral technology. These complementary

Takeda launches Kapidex for GERD treatment in US

Kapidex, available in 30mg and 60mg doses, was recently approved by the FDA for the treatment of heartburn associated with symptomatic non-erosive gastroesophageal reflux disease (GERD), the healing

Home Diagnostics names new president and CEO

The appointment concludes the executive search undertaken by the board of directors in November 2008 to identify a replacement for Richard Damron, Jr, who served in the same

Endocyte initiates Phase II ovarian cancer trial

The Phase II trial, also called the ‘Precedent study’, will evaluate the efficacy and safety of EC145 when administered in combination with pegylated liposomal doxorubicin (PLD). PLD is

Merit Medical to acquire assets of Alveolus

The purchase price of the Alveolus assets is approximately $19 million, subject to post-closing adjustments. The Alveolus assets consist primarily of an intellectual property portfolio, inventory, receivables and